Merck India appoints Pratima Reddy as Country Speaker
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
The launch of HULIO in the United States is an important milestone for Biocon Biologics
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
The successful outcome of this study represents an important milestone in Dr. Reddy's commitment to make highquality biosimilar products more accessible and affordable
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
Subscribe To Our Newsletter & Stay Updated